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To begin with, Human Pharmacology is a moderately priced book that makes no
pretense tobe as encyclopedic as Goodman and Gilman. Oneofthemain advantages
of the book is its consistency of presentation. Each chapter is presented in five
sections: (1) therapeutic overview; (2) mechanisms of action; (3) pharmacokinetics;
(4) relation ofmechanisms ofaction to clinical response; and (5) side effects, clinical
problems, and toxicity. This arrangement allows the reader to develop a consistent
and organized framework for understanding each major class ofdrugs.
Human Phannacology is particularly good in presenting the mechanisms of action
of each drug class. The generous use of color and diagrams, combined with concise
and simple explanations, adds to the clarity ofthe presentations. This fact alone may
allow the book to stand out, as mechanisms ofaction are, sadly, presented in a bland
and enigmatic manner in most other texts. In addition, the authors make a genuine
effort to relate the mechanism of action to the clinical response of the drug, which
adds invaluably to the student's appreciation ofthe subject matter.
As I forewarned in my caveat to this review, however, all texts have their
shortcomings. Ironically, in Human Phannacology, one of its shortcomings stems
from one of its strengths. In trying to present the mechanisms of action in as clear
and simple a manner aspossible, the authors have risked oversimplifying some ofthe
processes and masked some of the complexities involved that are required for
understanding the toxicity of some of the drugs. Despite the general clarity of the
other sections in each chapter, the pharmacokinetics section often seems to be the
mostconfusing. It is ahodgepodge collection ofdetails, some ofwhich are important,
some of which are not. The section is never divided into absorption, distribution,
metabolism, and excretion, even when appropriate, and seldom divided into drug
subclasses (e.g., antidepressants into tricyclics, second generation, and monoamine
oxidase inhibitors), even ifdoing sowould add greatly to the clarity ofthe section.
In conclusion, I think it isobvious thatHumanPhannacology should notbe used as
a reference text. The clear and colorful presentation ofits subject matter is obtained
at the expense of pharmacokinetic and pharmacodynamic lack of detail. This
presentation may, however, appeal tofirst-time students ofthe subject. I cannot help
but thinkthat thisbookmaynotbe adequate formedical studentswhomight desire a
textbookwith greater depth and substance.
BENHUR LEE
MedicalStudent
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FRAGILE X/CANCER CYTOGENETICS. Edited by Ann M. Willey and Patricia D.
Murphy. New York, John Wiley & Sons, Inc., 1991. 203 pp. $69.50.
This book is the publication of the 1989 Albany Birth Defects Symposium XX,
held in Albany, New York. Divided into two sections, a long one on fragile X
syndrome and a shorter one on cancer cytogenetics, each chapter represents a talk
given by one of the contributors at the conference. The clinical information pre-
sented in the section on fragile X is interesting and helpful, and provides a useful
compilation ofthe clinical featuresofthe condition. The contribution bySherman on
genetic epidemiology contains helpful information on expression of this condition
within families, on the confusing aspects of transmission within families, and on
prevalence in population studies. There are representative pedigrees demonstrating146 BOOK REVIEWS
the variable expression in families. Of note, however, in the fact that the identifica-
tion of the defect at the molecular level, recently published by Sherman and others,
has made much ofthe molecular marker information presented here obsolete. Many
of the confusing aspects of the reported pedigrees can now be explained by the
observation of a variable number of CGG repeats at the fragile X locus, an
observation that has rendered the inferential molecular studies and cytogenetic
methods obsolete for family studies, and nearly so for diagnostic purposes.
The contributions on cancer cytogenetics are interesting, though limited. The
review by Sandberg was up to date in 1989, and the reader would find it helpful,
though supplemental reading must be done to update it further. There are a number
ofwell-reproduced karyotypeswhich provide examples ofcytogenetic abnormalities.
Wolman provides a nice review paper.
The clinical and epidemiological information is still applicable, but the rest ofthe
fragile Xcontributions now have limitedvalue since the publication ofthe molecular
definition ofthe syndrome. The bookwill therefore be ofuse to specialists interested
inthebackground and history, readerswhowantclinical details, and those interested
in cancer cytogenetics. It will be of less use to students, generalists, and those
interested in the latest advances in our understanding offragile X.
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THE GENETIC REVOLUTION. SCIENTIFIC PROSPECTS AND PUBLIC PERCEPTIONS. Edited
byBernard D. Davis. Baltimore, MD, The Johns Hopkins University Press, 1991. 295
pp. $15.95. Paperbound.
This delightful volume is a collection of essays written about the advances in
molecular genetics over the past century. The authors comprise a list ofluminaries in
modern genetics as well as experts in other areas, many of whom speak from the
perspective of those who have watched the developments in genetics over a profes-
sional lifetime. The purpose ofthe bookis no less than to layout the developments in
molecular genetics and to discuss their implications for the world: the environment,
the future of science, even the future ofmankind. The audience is the educated and
thoughtful non-scientist, aswell as the concerned scientist.
The perspectives of a molecular geneticist, an ecologist, and an environmentalist
on the recombinant DNA controversy make fascinating reading. At the same time,
they present the arguments for the use ofthis powerful technology and the reminder
that some of our technical advances have been ecological time bombs. Ofparticular
interest are the discussions about the debate on the environmental release of
engineered microorganisms. Both Allen Campbell and Simon Levin point out that
the answers to these questions turn lessonthe fact that the organisms are engineered
than on their use and purpose. It is a humbling reminder that some events which
appear to be great scientific advances have already happened spontaneously in
nature; the scientist only learns how to perform them in a planned manner. As the
lawyer, Richard Stewart, reminds the reader, "genetic engineering by selective
breeding is an ancient practice."
Neuroscience, evolution, molecular medicine, government regulation of science,
all provide the stuffofwide-ranging essays. The discussions are balanced, thoughtful,